Oral Abstract Session
Late-Breaking Research Orals: AKI, CKD, CKM, and More
October 23, 2026 | 04:30 PM - 06:00 PM
Location: Four Seasons Ballroom 2, Convention Center
Session Description
Late-Breaking Research Orals, Part 2
Note: Continuing education credits are not being offered for this session.
Learning Pathway(s)
- AKI and Critical Care
- CKD Non-Dialysis
Moderators
Presentations
Acute Treatment of Hyperkalemia in the Emergency Department: A Randomized Clinical Trial
Isuzinaxib Preserves Kidney Function in Patients with CKD Undergoing Percutaneous Coronary Intervention for Contrast-Induced AKI: A Randomized, Double-Blind, Phase 2 Trial
CONCORD: A Randomized Controlled Trial of Novel Therapies for Depression in Patients with CKD
Effectiveness of Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Protein-Based Vaccine in Individuals with and Without CKD: A Prespecified Analysis of the DAN-RSV Trial
Efficacy and Safety of Upacicalcet in Patients with Secondary Hyperparathyroidism (SHPT) on Hemodialysis: Two Randomized Controlled Clinical Trials (RCTs)
Effects of Low-Dose Rivaroxaban on Cardiovascular Events in Patients with Advanced Kidney Disease According to Baseline Aspirin Use: A Prespecified Subgroup Analysis of the TRACK Trial
Prognostic Significance of eGFR Change at Week 12 on Kidney Outcomes Associated with Semaglutide Use in the FLOW Trial